Current SATVI news
On Friday 24 March 2017 the South African Tuberculosis Vaccine Initiative kicked off its World TB Day program at the Zwelethemba Public Library in Worcester. The program, which will include the exhibit of graffiti walls and poster art, the screening of TB educational videos and story reading for children, will be taken to four (4) libraries in and around Worcester.
SATVI authors have published an article titled "Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol" appearing in the British Medical Journal.
SATVI authors Professor Mark Hatherill and Associate Professor Tom Scriba have co-authored a paper titled: "Policy-interventions: Tuberculosis" appearing in the British Medical Journal Global Health.
Dr Michele Tameris, SATVI Investigator has been awarded accreditation as an Established Researcher by the National Research Foundation, having recently been rated in the category C1, in acknowledgement of national and international standing.
SATVI authors Professor Mark Hatherill, Associate Professor Tom Scriba and Dr Munyaradzi Musvosvi have co-authored a paper titled "The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes" appearing in the Tuberculosis Journal.
Researchers from the South African Tuberculosis Vaccine Initiative, the universities of Stanford, Oxford and the London School of Hygiene & Tropical Medicine, have shown that a blood test usually used to detect tuberculosis infection in adults, can predict the onset of tuberculosis disease in young children. This article features in the latest Lancet: Respiratory Medicine.
UCT Health Sciences Faculty recently said farewell to Professor Greg Hussey, founding Director of SATVI, (Director: Vaccines for Africa and Interim Director of the HSF 2015-2016) upon his retirement.
SATVI author, Associate Professor Tom Scriba has co-authored a paper titled "Safety and Immunogenicity of Adenovirus 35 TB Vaccine Candidate in Adults with Active or Previous TB: a Randomized Trial" appearing in the American Journal of Respiratory and Critical Care Medicine.
SATVI authors Dr Adam Penn-Nicholson, Associate Professor Tom Scriba and Professor Mark Hatherill have published a paper titled "A novel blood test for tuberculosis prevention and treatment" appearing in the January edition of the South African Medical Journal.
Dr Sara Suliman, Postdoctoral Fellow has departed from SATVI to take up a postdoctoral fellowship at the Brigham and Women's Hospital at Harvard Medical School.
We invite applications from suitably qualified candidates for a vacancy as Senior Scientific Officer in the Immunology Laboratory of the South African Tuberculosis Vaccine Initiative. CLOSED
SATVI authors have published a paper titled "H1:IC31 vaccination is safe and induces long-lived TNF-a+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial" appearing in the Vaccine Journal.